• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4673303)   Today's Articles (6081)
For: Matsumoto T. Membrane destabilizing activity of influenza virus hemagglutinin-based synthetic peptide: implications of critical glycine residue in fusion peptide. Biophys Chem 1999;79:153-62. [PMID: 10389239 DOI: 10.1016/s0301-4622(99)00051-4] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Number Cited by Other Article(s)
1
Rice A, Zimmerberg J, Pastor RW. Initiation and evolution of pores formed by influenza fusion peptides probed by lysolipid inclusion. Biophys J 2023;122:1018-1032. [PMID: 36575795 PMCID: PMC10111278 DOI: 10.1016/j.bpj.2022.12.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 12/09/2022] [Accepted: 12/21/2022] [Indexed: 12/28/2022]  Open
2
Rice A, Haldar S, Wang E, Blank PS, Akimov SA, Galimzyanov TR, Pastor RW, Zimmerberg J. Planar aggregation of the influenza viral fusion peptide alters membrane structure and hydration, promoting poration. Nat Commun 2022;13:7336. [PMID: 36470871 PMCID: PMC9722698 DOI: 10.1038/s41467-022-34576-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2021] [Accepted: 10/28/2022] [Indexed: 12/07/2022]  Open
3
Kardani K, Milani A, H Shabani S, Bolhassani A. Cell penetrating peptides: the potent multi-cargo intracellular carriers. Expert Opin Drug Deliv 2019;16:1227-1258. [PMID: 31583914 DOI: 10.1080/17425247.2019.1676720] [Citation(s) in RCA: 132] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
4
Reissmann S. Cell penetration: scope and limitations by the application of cell-penetrating peptides. J Pept Sci 2014;20:760-84. [DOI: 10.1002/psc.2672] [Citation(s) in RCA: 176] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2014] [Revised: 06/06/2014] [Accepted: 06/10/2014] [Indexed: 12/23/2022]
5
Tenchov BG, MacDonald RC, Lentz BR. Fusion peptides promote formation of bilayer cubic phases in lipid dispersions. An x-ray diffraction study. Biophys J 2013;104:1029-37. [PMID: 23473485 DOI: 10.1016/j.bpj.2012.12.034] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2012] [Revised: 12/08/2012] [Accepted: 12/17/2012] [Indexed: 10/27/2022]  Open
6
Dubovskii PV. Unusual titration of the membrane-bound artificial hemagglutinin fusion peptide. EUROPEAN BIOPHYSICS JOURNAL: EBJ 2012;41:1077-84. [DOI: 10.1007/s00249-012-0867-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2012] [Revised: 09/25/2012] [Accepted: 10/04/2012] [Indexed: 11/28/2022]
7
Promsri S, Ullmann GM, Hannongbua S. Molecular dynamics simulation of HIV-1 fusion domain-membrane complexes: Insight into the N-terminal gp41 fusion mechanism. Biophys Chem 2012;170:9-16. [DOI: 10.1016/j.bpc.2012.07.002] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2010] [Revised: 06/24/2012] [Accepted: 07/09/2012] [Indexed: 11/26/2022]
8
Haque ME, Chakraborty H, Koklic T, Komatsu H, Axelsen PH, Lentz BR. Hemagglutinin fusion peptide mutants in model membranes: structural properties, membrane physical properties, and PEG-mediated fusion. Biophys J 2011;101:1095-104. [PMID: 21889446 DOI: 10.1016/j.bpj.2011.07.031] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2011] [Revised: 06/23/2011] [Accepted: 07/08/2011] [Indexed: 10/17/2022]  Open
9
Solaro R. Targeted delivery of proteins by nanosized carriers. ACTA ACUST UNITED AC 2007. [DOI: 10.1002/pola.22388] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
10
Sammalkorpi M, Lazaridis T. Configuration of influenza hemagglutinin fusion peptide monomers and oligomers in membranes. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2007;1768:30-8. [PMID: 16999933 DOI: 10.1016/j.bbamem.2006.08.008] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/11/2006] [Revised: 08/01/2006] [Accepted: 08/02/2006] [Indexed: 10/24/2022]
11
Haque ME, Koppaka V, Axelsen PH, Lentz BR. Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion. Biophys J 2005;89:3183-94. [PMID: 16183890 PMCID: PMC1366814 DOI: 10.1529/biophysj.105.063032] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2005] [Accepted: 07/26/2005] [Indexed: 11/18/2022]  Open
12
Bertocco A, Formaggio F, Toniolo C, Broxterman QB, Epand RF, Epand RM. Design and function of a conformationally restricted analog of the influenza virus fusion peptide. THE JOURNAL OF PEPTIDE RESEARCH : OFFICIAL JOURNAL OF THE AMERICAN PEPTIDE SOCIETY 2003;62:19-26. [PMID: 12787447 DOI: 10.1034/j.1399-3011.2003.00063.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
13
Mastrobattista E, Koning GA, van Bloois L, Filipe ACS, Jiskoot W, Storm G. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J Biol Chem 2002;277:27135-43. [PMID: 12021269 DOI: 10.1074/jbc.m200429200] [Citation(s) in RCA: 146] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
14
Hsu CH, Wu SH, Chang DK, Chen C. Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin. Implication of the necessity of a helix-hinge-helix motif in fusion activity. J Biol Chem 2002;277:22725-33. [PMID: 11937502 DOI: 10.1074/jbc.m200089200] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
15
Gariépy J, Kawamura K. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol 2001;19:21-8. [PMID: 11146099 DOI: 10.1016/s0167-7799(00)01520-1] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
16
Dubovskii PV, Li H, Takahashi S, Arseniev AS, Akasaka K. Structure of an analog of fusion peptide from hemagglutinin. Protein Sci 2000;9:786-98. [PMID: 10794422 PMCID: PMC2144621 DOI: 10.1110/ps.9.4.786] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA